test

Steve R. Bailey

@Frazier Life Sciences Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$2.495BTotal holdings53
Assets growth rate16.72%Assets growth rate (2-Q avg)3.46%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Frazier Life Sciences Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 53 positions.

Assets under management

The assets under management (AUM) of Frazier Life Sciences Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.495B in assets, with a quarterly growth rate of 16.72% and a 2-quarter average growth rate of 3.46%. The portfolio is managed by Steve R. Bailey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MIRMMirum Pharmaceuticals Inc
Recent Activity
Increased 1.16%
10.28%
$256.245M
6.57M shares@ $39.0 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
Increased 5.14%
8.56%
$213.396M
12.855M shares@ $16.6 avg price
RYTMRhythm Pharmaceuticals Inc
Recent Activity
Increased 1.93%
5.08%
$126.624M
2.417M shares@ $52.39 avg price
VRNAVerona Pharma Plc
Recent Activity
Increased 2.1%
3.91%
$97.356M
3.384M shares@ $28.78 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Increased 3.52%
3.84%
$95.741M
3.76M shares@ $25.46 avg price
ANABAnaptysbio Inc
Recent Activity
Increased 2.02%
2.97%
$74.008M
2.209M shares@ $33.51 avg price
ERASErasca Inc
Recent Activity
Increased 19.59%
2.13%
$52.939M
19.392M shares@ $2.74 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
Increased 19.75%
1.86%
$46.392M
1.044M shares@ $44.43 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Increased 49.11%
1.42%
$35.203M
633,715 shares@ $55.55 avg price
MREOMereo Biopharma Group Plc
Recent Activity
Increased 15.83%
0.84%
$20.952M
5.098M shares@ $4.12 avg price